Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and April 2017

Showing 1 to 10 of 327
Title Reference number Published Last updated
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine Reference number:TA440 TA00440 Published:April 2017 20170401 Last updated:April 2017 20170426
Daclizumab for treating relapsing–remitting multiple sclerosis Reference number:TA441 TA00441 Published:April 2017 20170401 Last updated:April 2017 20170426
Ixekizumab for treating moderate to severe plaque psoriasis Reference number:TA442 TA00442 Published:April 2017 20170401 Last updated:April 2017 20170426
Obeticholic acid for treating primary biliary cholangitis Reference number:TA443 TA00443 Published:April 2017 20170401 Last updated:April 2017 20170426
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal) Reference number:TA438 TA00438 Published:March 2017 20170301 Last updated:March 2017 20170329
Cetuximab and panitumumab for previously untreated metastatic colorectal cancer Reference number:TA439 TA00439 Published:March 2017 20170301 Last updated:March 2017 20170329
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) Reference number:TA240 TA00240 Published:December 2011 20111201 Last updated:March 2017 20170329
Elotuzumab for previously treated multiple myeloma (terminated appraisal) Reference number:TA434 TA00434 Published:March 2017 20170301 Last updated:March 2017 20170322
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) Reference number:TA435 TA00435 Published:March 2017 20170301 Last updated:March 2017 20170322
Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal) Reference number:TA436 TA00436 Published:March 2017 20170301 Last updated:March 2017 20170322